In support of FDA funding increases
As the Alliance for a Stronger FDA notes, the US House approved a 7 percent increase to the Food and Drug Administration for fiscal year 2011 even as most federal agencies will be funded at the same level as 2010. This is a welcome commitment – and one that the Senate should match as it considers how to support the FDA.
More importantly, increased funding of the agency must continue in the coming years if the FDA is to protect patient health as it manages a growing list of complex public health responsibilities.
That is why AstraZeneca is urging the Obama Administration to give the FDA a 20 percent increase for the fiscal year 2012 budget.
“We remain committed to doing what we can to help the FDA meet its needs,” Rich Fante, President AstraZeneca US & Regional VP North America, wrote in a letter to Health Human Services Secretary Kathleen Sebelius. “But we believe Congress and the President must support this critical need as well by providing the funding the FDA requires to fulfill its mission.”
In supporting an increase in funding for the agency, AstraZeneca seeks to ensure the FDA has the resources it needs to effectively oversee the quality and safety of medical treatments, cosmetics and the food supply, while also taking on such serious threats as bioterrorism, infectious disease outbreaks and other public health emergencies.
Visit the Alliance for a Stronger FDA for updates on the FDA budgetary process.
– By Tony Jewell